• DE
  • EN
  • RU
+49 89 54 21 430 Contact
Dr. Sennewald Medizintechnik GmbH
  • Home
  • Products
    • BSD‑500
    • BSD‑2000
    • BSD‑2000 3D
    • BSD‑2000 3D/MR
    • Sigmavision Advanced
  • Clinical Evidence
    • Key Indications
    • BSD‑500 & BSD‑2000 clinical studies
  • Knowledge base
    • Organizations
    • General Information
    • Brochures
    • Videos
    • In the Press
  • About Us
    • Our Company
    • Newsletter
    • Events
    • References

Hyperthermia
Video Library

Our Videos Pyrexar Videos TV reports Scientific Sessions
ICHO 2021

ICHO 2021

Prof. Gerard van Rhoon

ICHO 2021

Prof. Gerard van Rhoon

ESHO-Pyrexar-Award: Niloy Datta
ESHO-Pyrexar-Award: Niloy Datta

ESHO-Pyrexar-Award: Niloy Datta

Prof. Niloy Datta

Targeted NK cell based adoptive immunotherapy for the treatment with NSCLC after radiochemotherapy
Targeted NK cell based adoptive immunotherapy for the treatment with NSCLC after radiochemotherapy

Targeted NK cell based adoptive immunotherapy for the treatment with NSCLC after radiochemotherapy

Combined regional hyperthermia and salvage radiation therapy for prostate cancer after prostatectomy
Combined regional hyperthermia and salvage radiation therapy for prostate cancer after prostatectomy

Combined regional hyperthermia and salvage radiation therapy for prostate cancer after prostatectomy

Hyperthermia in combination with chemotherapy for patient with soft tissue sarcoma
Hyperthermia in combination with chemotherapy for patient with soft tissue sarcoma

Hyperthermia in combination with chemotherapy for patient with soft tissue sarcoma

Pancreatic cancer comparing chemotherapy alone vs. chemotherapy plus hyperthermia
Pancreatic cancer comparing chemotherapy alone vs. chemotherapy plus hyperthermia

Pancreatic cancer comparing chemotherapy alone vs. chemotherapy plus hyperthermia

Hyperthermia for breast and cervical cancer - an overview
Hyperthermia for breast and cervical cancer - an overview

Hyperthermia for breast and cervical cancer - an overview

Towards Hyperthermia as the 4th Pillar in Oncology
Towards Hyperthermia as the 4th Pillar in Oncology

Towards Hyperthermia as the 4th Pillar in Oncology

ESHO Impressions
ESHO Impressions

ESHO Impressions

The ESHO video, including short interviews, is available on the PTHO’s YouTube channel

Lecture
Lecture

Lecture

Deep RF Hyperthermia – Technical Historical Review

Do you want to meet us in person? Contact us

Products

  • BSD‑500
  • BSD‑2000
  • BSD‑2000 3D
  • BSD‑2000 3D/MR
  • Sigmavision Advanced

Clinical Evidence

  • Key Indications
  • BSD‑500 & BSD‑2000 clinical studies

Knowledge base

  • Organizations
  • General Information
  • Brochures
  • Videos
  • In the Press

About Us

  • Our Company
  • Newsletter
  • Events
  • References
  • Privacy Policy

Company

Dr. Sennewald Medizintechnik GmbH was founded in 1985 by Dr. Gerhard Sennewald in Munich with the goal of discovering trendsetting electro-medical systems providing innovative and beneficial medical treatments and introducing them in Europe. From the beginning, cancer therapy was in the forefront of the company, with a focus on regional and local hyperthermia.

more information

Contact

  • Schatzbogen 86
    81829 Munich
    Germany
  • +49 89 54 21 430
  • sales@sennewald.de
  • www.sennewald.de
© 2023 Dr. Sennewald Medizintechnik GmbH | Legal Notice
  • YouTube
  • LinkedIn
  • Facebook
  • Twitter